408 related articles for article (PubMed ID: 19926811)
1. A mathematical model of homeostatic regulation of sleep-wake cycles by hypocretin/orexin.
Postnova S; Voigt K; Braun HA
J Biol Rhythms; 2009 Dec; 24(6):523-35. PubMed ID: 19926811
[TBL] [Abstract][Full Text] [Related]
2. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis.
Sakurai T
Sleep Med Rev; 2005 Aug; 9(4):231-41. PubMed ID: 15961331
[TBL] [Abstract][Full Text] [Related]
3. Dynamic interactions between orexin and dynorphin may delay onset of functional orexin effects: a modeling study.
Williams KS; Behn CG
J Biol Rhythms; 2011 Apr; 26(2):171-81. PubMed ID: 21454297
[TBL] [Abstract][Full Text] [Related]
4. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.
Takahashi K; Lin JS; Sakai K
Neuroscience; 2008 May; 153(3):860-70. PubMed ID: 18424001
[TBL] [Abstract][Full Text] [Related]
5. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
Terao A; Haruyama T; Kimura K
Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
[TBL] [Abstract][Full Text] [Related]
6. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
Ohno K; Sakurai T
Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
[TBL] [Abstract][Full Text] [Related]
7. The orexin system: roles in sleep/wake regulation.
Sakurai T; Mieda M; Tsujino N
Ann N Y Acad Sci; 2010 Jul; 1200():149-61. PubMed ID: 20633143
[TBL] [Abstract][Full Text] [Related]
8. Characterization of sleep-wake patterns in a novel transgenic mouse line overexpressing human prepro-orexin/hypocretin.
Mäkelä KA; Wigren HK; Zant JC; Sakurai T; Alhonen L; Kostin A; Porkka-Heiskanen T; Herzig KH
Acta Physiol (Oxf); 2010 Mar; 198(3):237-49. PubMed ID: 20003098
[TBL] [Abstract][Full Text] [Related]
9. Non-sleep effects of hypocretin/orexin.
Samson WK; Taylor MM; Ferguson AV
Sleep Med Rev; 2005 Aug; 9(4):243-52. PubMed ID: 16036174
[TBL] [Abstract][Full Text] [Related]
10. The dual role of the orexin/hypocretin system in modulating wakefulness and respiratory drive.
Gestreau C; Bévengut M; Dutschmann M
Curr Opin Pulm Med; 2008 Nov; 14(6):512-8. PubMed ID: 18812827
[TBL] [Abstract][Full Text] [Related]
11. Overview of orexin/hypocretin system.
Mieda M; Sakurai T
Prog Brain Res; 2012; 198():5-14. PubMed ID: 22813966
[TBL] [Abstract][Full Text] [Related]
12. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
Beuckmann CT; Yanagisawa M
J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
[TBL] [Abstract][Full Text] [Related]
13. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats.
Thakkar MM; Ramesh V; Strecker RE; McCarley RW
Arch Ital Biol; 2001 Apr; 139(3):313-28. PubMed ID: 11330208
[TBL] [Abstract][Full Text] [Related]
14. Activity-dependent release of adenosine inhibits the glutamatergic synaptic transmission and plasticity in the hypothalamic hypocretin/orexin neurons.
Xia J; Chen F; Ye J; Yan J; Wang H; Duan S; Hu Z
Neuroscience; 2009 Sep; 162(4):980-8. PubMed ID: 19465088
[TBL] [Abstract][Full Text] [Related]
15. Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro.
Ishibashi M; Takano S; Yanagida H; Takatsuna M; Nakajima K; Oomura Y; Wayner MJ; Sasaki K
Peptides; 2005 Mar; 26(3):471-81. PubMed ID: 15652654
[TBL] [Abstract][Full Text] [Related]
16. A quartet neural system model orchestrating sleep and wakefulness mechanisms.
Tamakawa Y; Karashima A; Koyama Y; Katayama N; Nakao M
J Neurophysiol; 2006 Apr; 95(4):2055-69. PubMed ID: 16282204
[TBL] [Abstract][Full Text] [Related]
17. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
Baumann CR; Bassetti CL
Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
[TBL] [Abstract][Full Text] [Related]
18. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice.
Sakurai T; Nagata R; Yamanaka A; Kawamura H; Tsujino N; Muraki Y; Kageyama H; Kunita S; Takahashi S; Goto K; Koyama Y; Shioda S; Yanagisawa M
Neuron; 2005 Apr; 46(2):297-308. PubMed ID: 15848807
[TBL] [Abstract][Full Text] [Related]
19. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons.
Eriksson KS; Sergeeva OA; Selbach O; Haas HL
Eur J Neurosci; 2004 Mar; 19(5):1278-84. PubMed ID: 15016085
[TBL] [Abstract][Full Text] [Related]
20. Orexins/hypocretins and aminergic systems.
Eriksson KS; Sergeeva OA; Haas HL; Selbach O
Acta Physiol (Oxf); 2010 Mar; 198(3):263-75. PubMed ID: 19566795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
